Persons
Webseiten-Inhalte
New CBmed Core Lab opened at MedUni Vienna
...All News – University, Medicine & Science from left: n.r.: Georg Steiner (CEO TissueGnostics), Thomas Pieber (CSO K1-Kompetenzzentrum CBmed), Rector Markus Müller, Robert Fasching (CBmed), Rudolf Oehler (Cbmed/MedUni Vienna), Vice-rector Michaela Fritz, Franz Wurm (MedUni Vienna/Supervisory Board CBmed), Lukas Kenner (MedUni Vienna). (Vienna, 08 July 2016) – The Austrian research center CBmed (Center for Biomarker Research in Medicine) officially opens a new Core Lab at the Medical University of Vienna. The proteomics laboratory uses completely new methods to identify...
https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2016/news-from-july-2016/new-cbmed-core-lab-opened-at-meduni-vienna/medicine-science/
Neue therapeutische Hoffnung bei aggressiver T-PLL-Leukämie
..., Bernadette Hilgarth, Wolfgang R. Sperr, Peter Valent, Ingrid Simonitsch-Klupp, Richard Moriggl, Olaf Merkel, Lukas Kenner, Ulrich Jäger, Stefan Kubicek, Philipp B. Staber. Online: https://www.ncbi.nlm.nih.gov/pubmed/28972014. Blood (IF: 13.2). DOI: 10.1182/blood-2017-05-785683 Share Whatsapp Facebook...
https://www.meduniwien.ac.at/web/ueber-uns/news/detailseite/2017/news-im-oktober-2017/neue-therapeutische-hoffnung-bei-aggressiver-t-pll-leukaemie/
Neue therapeutische Hoffnung bei aggressiver T-PLL-Leukämie
..., Bernadette Hilgarth, Wolfgang R. Sperr, Peter Valent, Ingrid Simonitsch-Klupp, Richard Moriggl, Olaf Merkel, Lukas Kenner, Ulrich Jäger, Stefan Kubicek, Philipp B. Staber. Online: https://www.ncbi.nlm.nih.gov/pubmed/28972014. Blood (IF: 13.2). DOI: 10.1182/blood-2017-05-785683 Share Whatsapp Facebook...
https://www.meduniwien.ac.at/web/ueber-uns/news/detailseite/2017/news-im-oktober-2017/neue-therapeutische-hoffnung-bei-aggressiver-t-pll-leukaemie/medizin-wissenschaft/
New hope of a treatment for aggressive T-PLL leukaemia
... Hilgarth, Wolfgang R. Sperr, Peter Valent, Ingrid Simonitsch-Klupp, Richard Moriggl, Olaf Merkel, Lukas Kenner, Ulrich Jäger, Stefan Kubicek, Philipp B. Staber. Online: https://www.ncbi.nlm.nih.gov/pubmed/28972014. Blood (IF: 13.2). DOI: 10.1182/blood-2017-05-785683 Share Whatsapp Facebook Twitter...
https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2017/news-im-oktober-2017/new-hope-of-a-treatment-for-aggressive-t-pll-leukaemia/medicine-science/
New hope of a treatment for aggressive T-PLL leukaemia
... Hilgarth, Wolfgang R. Sperr, Peter Valent, Ingrid Simonitsch-Klupp, Richard Moriggl, Olaf Merkel, Lukas Kenner, Ulrich Jäger, Stefan Kubicek, Philipp B. Staber. Online: https://www.ncbi.nlm.nih.gov/pubmed/28972014. Blood (IF: 13.2). DOI: 10.1182/blood-2017-05-785683 Share Whatsapp Facebook Twitter...
https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2017/news-im-oktober-2017/new-hope-of-a-treatment-for-aggressive-t-pll-leukaemia/
Supervisors | MedUni Wien
...; E-Mail: BARTHA-DÖHRING Elisabeth E-Mail: FEUCHT Martha E-Mail: GOJO Johannes E-Mail: KLEBERMASS-SCHREHOF Katrin E-Mail: RESCH Monika E-Mail: SLAVC Irene E-Mail: WENINGER Manfred » Institute of Pathology E-Mail: KENNER Lukas » Department of Plastic and Reconstructive Surgery E-Mail: ASZMANN Oskar...
https://www.meduniwien.ac.at/web/studium-weiterbildung/phd-und-doktoratsstudien/doktoratsstudium-der-angewandten-medizinischen-wissenschaft-un790/thematische-programme/clinical-neurosciences/about-the-program/supervisorinnen/
Established cancer drugs effective in aggressive leukaemia with STAT5 mutations
..., Thomas Kolbe, Mohamed Elabd, Florian Halbritter, Jan Pencik, Zahra Kazemi, Florian Grebien, Markus Hengstschläger, Lukas Kenner, Stefan Kubicek, Matthias Farlik, Christoph Bock, Peter Valent, Mathias Müller, Thomas Rülicke, Veronika Sexl and Richard Moriggl in J Clin Invest. 2018;128(1): https://doi...
https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2017/news-im-dezember-2017/established-cancer-drugs-effective-in-aggressive-leukaemia-with-stat5-mutations/
Established cancer drugs effective in aggressive leukaemia with STAT5 mutations
..., Thomas Kolbe, Mohamed Elabd, Florian Halbritter, Jan Pencik, Zahra Kazemi, Florian Grebien, Markus Hengstschläger, Lukas Kenner, Stefan Kubicek, Matthias Farlik, Christoph Bock, Peter Valent, Mathias Müller, Thomas Rülicke, Veronika Sexl and Richard Moriggl in J Clin Invest. 2018;128(1): https://doi...
https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2017/news-im-dezember-2017/established-cancer-drugs-effective-in-aggressive-leukaemia-with-stat5-mutations/medicine-science/
Neue Studie eröffnet vielversprechende Therapieperspektive für seltenen Hautkrebs
..., David Horst, Anja Fischer, Reiner Siebert, Jan P Nicolay, Menghong Yin, Martin Janz, Falko Fend, Jürgen C Becker, Christian M Schürch, Lukas Kenner, Chalid Assaf, Olaf Merkel and Stephan Mathas Br J Dermatol 2025; 00:1–13 https://doi.org/10.1093/bjd/ljaf001 Studie als "Spotlight" der Charité...
https://www.meduniwien.ac.at/web/ueber-uns/news/2025/news-im-maerz-2025/neue-studie-eroeffnet-vielversprechende-therapieperspektive-fuer-seltenen-hautkrebs/
Neue Studie eröffnet vielversprechende Therapieperspektive für seltenen Hautkrebs
..., David Horst, Anja Fischer, Reiner Siebert, Jan P Nicolay, Menghong Yin, Martin Janz, Falko Fend, Jürgen C Becker, Christian M Schürch, Lukas Kenner, Chalid Assaf, Olaf Merkel and Stephan Mathas Br J Dermatol 2025; 00:1–13 https://doi.org/10.1093/bjd/ljaf001 Studie als "Spotlight" der Charité...
https://www.meduniwien.ac.at/web/ueber-uns/news/2025/news-im-maerz-2025/neue-studie-eroeffnet-vielversprechende-therapieperspektive-fuer-seltenen-hautkrebs/medizin-wissenschaft/